Evidence map›Paper›PMID 32886316›Full record

SynthesisEndocrine2020

Stanley M Chen Cardenas, Prasanna Santhanam

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Endocrine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. What We Know about and What Is New in Primary Aldosteronism.International journal of molecular sciences · 2024
    Review
  6. Article
  7. A comparison of the performance ofFrontiers in endocrinology · 2024
    Article
  8. Review
  9. Recent progress in the diagnosis and treatment of primary aldosteronism.Hypertension research : official journal of the Japanese Society of Hypertension · 2023
    Review
  10. Article
  11. Article
  12. Imaging in translational cancer research.Cancer biology & medicine · 2022
    Review
  13. Lateralization inEndocrinology, diabetes & metabolism · 2022
    Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Stanley M Chen CardenasDivision of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-7719-4729
Prasanna SanthanamDivision of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD, USA. psantha1@jhmi.edu.ORCID http://orcid.org/0000-0003-4822-2705
Johns Hopkins University · USUniversidad de Panamá · PA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdrenal masses are commonly encountered in clinical practice, many of whom are incidental. Identifying malignancy, and excess hormone production is essential for appropriate management. Biochemical workup and imaging tests (dedicated adrenal CT and/or MRI) are used to determine the likelihood of excessive hormone function and malignancy, respectively. However, imaging cannot provide information about function and biochemical workup cannot localize the source. Furthermore, in primary aldosteronism, adrenal vein sampling, the gold standard for lateralization, has important limitations such as the technical expertise required, the elevated costs, and potential complications. Over the last decades, there has been a renewed interest in alternative noninvasive imaging techniques that provide information about adrenal function without the need for invasive procedures. In this review, we will evaluate the evidence and the potential role of

methodsA review of the English literature for articles describing the use of the tracer

resultsA total of 12 studies were included in the systematic review, which altogether addressed the use of

conclusions

Indexed as

Adrenal Gland NeoplasmsEtomidateHyperaldosteronismHumansPositron-Emission TomographyTomography, X-Ray ComputedEtomidatemetomidate11C-metomidateAdrenal massesAdrenal tracerPositron emission tomographyPrimary aldosteronism

Identifiers

PMID32886316
OpenAlexW3083178307

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.